News Headlines Article

Trump administration abandons plans to limit drug rebates
Modern Healthcare

The Trump administration has withdrawn its proposal to eliminate drug rebates in Medicare and Medicaid plans, striking another significant blow to its broader plans to curb rising drug costs.

The proposed HHS rule, first unveiled in January, would have excluded the rebates drugmakers pay to pharmacy benefit managers from protections from anti-kickback laws.